J07BN02 COVID-19, viral vector, non-replicating
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 4 drugs in this drug class.
Place in the ATC system
- J Antiinfectives for systemic use 1,101 drugs
- J07 Vaccines 119 drugs
- J07B Viral vaccines 78 drugs
- J07BN02 COVID-19, viral vector, non-replicating 4 drugs
- J07B Viral vaccines 78 drugs
- J07 Vaccines 119 drugs
Active ingredients of the class
- Ad26.cov2.s [recombinant] 1 drug
- Chadox1-s [recombinant] 3 drugs
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Covishield PM | – |
| Jcovden | – |
| Vaxzevria (Astrazeneca Canada, PM 00062879) | – |
| Vaxzevria (Astrazeneca Canada, PM 00068758) | – |
Other classes of the same level
- J07BN01 COVID-19, rna-based vaccine 10 drugs
- J07BN04 COVID-19, protein subunit 3 drugs
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class J07BN02
Ask your doctor or pharmacist for advice.